Frank, Tobias <br/><br/>
Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease.  [electronic resource] 

 -  Brain : a journal of neurology  Jun 2012 
 - 1914-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2156 
<br/><br/><label>Standard No.: </label>10.1093/brain/aws054  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--adverse effects<br/>3,4-Dihydroxyphenylacetic Acid--metabolism<br/>Animals<br/>Brain--drug effects<br/>Chromatography, High Pressure Liquid<br/>Disease Models, Animal<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--metabolism<br/>Homovanillic Acid--metabolism<br/>Injections, Subcutaneous<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Motor Activity--drug effects<br/>Neurons--drug effects<br/>Neuroprotective Agents--therapeutic use<br/>Parkinson Disease--blood<br/>Polyethylene Glycols--metabolism<br/>Rats<br/>Rats, Wistar<br/>Recombinant Proteins--metabolism<br/>Rotarod Performance Test<br/>Time Factors<br/>Tyrosine 3-Monooxygenase--metabolism